- ChineseInvestors.com
offers first-rate financial information and innovative CBD products
- CBD is
poised to become one of China’s largest industries over the next decade
- CIIX
is at the vanguard of what may become the world’s largest CBD market
Offering an array of investor education products and
services, ChineseInvestors.com Inc. (OTCQB: CIIX) provides
web-based, real-time financial information in Chinese language character sets.
Not only is it a top financial information website for Chinese-speaking
investors in the U.S. and China, CIIX is also becoming a major player in the
emerging CBD (cannabidiol) market for CBD-based nutrition and health products
in China. The company is focusing back on its original mission of providing
financial information and services to the larger Chinese community in the U.S.
and globally while exploring major CDB market opportunities. As the disposable
income of the average Chinese consumer continues to grow, CIIX is making moves
to penetrate the steadily growing Chinese CBD market.
Through wholly owned enterprise CBD Biotech Inc., CIIX is
implementing its CBD initiatives. At present, CIIX is at the vanguard of what
may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The
company recognizes the untapped CBD market for Chinese-speaking individuals,
specifically in the health care sector, which is expected to grow by as much as
10 percent per year. Due to a higher spending power from consumers, China’s
demand for medicinal products such as those made from hemp-based CBD has risen.
Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX
is uniquely positioned to meet this consumer demand. CIIX is hoping for a
Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.
CIIX developed its unique niche by concentrating on the
Chinese-speaking markets where it has historically generated success. This bodes
well for its CBD strategy. The company has created a three-year development
plan to take advantage of mainland China’s interest in CBD-infused health and
wellness products. Realizing that CBD is anticipated to become one of China’s
largest industries over the next 10 years with a potential market of close to
two billion people, CIIX’s strategy aims to educate consumers about the
benefits of CBD oil.
CIIX is no stranger to the CBD market, as it operated one of
the first Chinese-language CBD stores online. It also opened its initial CBD
pop-up kiosk in Glendale Galleria Mall in California. This past February, CIIX
launched its rebranded CBD consumer product line and consolidated its retail
ecommerce outlets into a single site, www.365CWC.com. CIIX now offers consumers opt Hemp, which
includes products infused with industrial hemp derived CDB. It additionally
offers opt2mist(TM), a spray vitamin product line featuring full spectrum
hemp-derived CBD-infused formulas.
CBD Biotech has its own product lines specifically designed
for the Chinese market internationally. These include CBD Biotech’s Live Oxygen
Series and its Magic Hemp Series.
The numbers show support for CIIX’s CBD-driven direction.
Hemp and CBD sales were a key driver in its recent robust quarterly
performance. For the third quarter of FY2019, ended February 28, 2019, CIIX
reported total revenue of $1.4 million. This represents an increase of 81
percent from the same quarter of FY2018. Hemp and CBD sales increased almost
600 percent in Q3, reaching $1.1 million. Recently, CBD Biotech was a featured
exhibitor at the Vietnam Expo, where it introduced its hemp-infused skincare
line and hemp wine, which is expected to add to future sales growth.
CIIX continues to focus on investor education products and
services and compelling CDB opportunities. The company offers investors the
potential for portfolio gain because of its focus on highly diversified revenue
streams. With its emphasis on premier financial information as well as high
quality hemp-based CBD products, CIIX continues its march toward greater growth
and profits for all its stakeholders.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates
relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
